Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calcium-dependent surface glycoproteins.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 8502162)

Published in Microb Pathog on February 01, 1993

Authors

S A Klotz1, M J Rutten, R L Smith, S R Babcock, M D Cunningham

Author Affiliations

1: Department of Medicine, Veterans Affairs Medical Center, Kansas City, MO.

Articles citing this

Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev (1998) 4.14

Penetration and damage of endothelial cells by Candida albicans. Infect Immun (1995) 2.67

Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions. Infect Immun (1996) 1.52

The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun (1998) 1.42

The fibronectin adhesin of Candida albicans. Infect Immun (1994) 1.22

Cloning and characterization of CAD1/AAF1, a gene from Candida albicans that induces adherence to endothelial cells after expression in Saccharomyces cerevisiae. Infect Immun (1998) 1.10

Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol (2001) 1.07

Binding of Candida albicans to immobilized amino acids and bovine serum albumin. Infect Immun (1998) 1.03

Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest (1998) 0.99

Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans. Infect Immun (1995) 0.84

Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLoS One (2014) 0.84

Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J Biol Chem (2011) 0.83

Adherence of Candida albicans to endothelial cells is inhibited by prostaglandin I2. Infect Immun (1994) 0.82

Ca ions stabilize the binding of complement factor iC3b to the pseudohyphal form of Candida albicans. Infect Immun (1994) 0.75

Articles by these authors

(truncated to the top 100)

Chicken liver ribosomes: characterization of cross-reaction and inhibition of some functions by antibodies prepared against Escherichia coli ribosomal proteins L7 and L12. J Mol Biol (1976) 12.86

Polymorphic hydroxylation of Debrisoquine in man. Lancet (1977) 9.36

Changes in physicians' attitudes toward telling the cancer patient. JAMA (1979) 7.75

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68

Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion. Biochem J (1967) 5.33

More on SI units. N Engl J Med (1992) 4.34

Biliary excretion of foreign compounds. Benzene and its derivatives in the rat. Biochem J (1967) 3.97

Lowry determination of protein in the presence of Triton X-100. Anal Biochem (1975) 3.94

Polymorphism of carbon oxidation of drugs and clinical implications. Br Med J (1978) 3.90

Effect of organic contamination upon microbial distributions and heterotrophic uptake in a Cape Cod, Mass., aquifer. Appl Environ Microbiol (1984) 3.06

Denitrification in san francisco bay intertidal sediments. Appl Environ Microbiol (1984) 3.03

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest (1996) 2.94

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (1993) 2.60

Phosphate-regulated inactivation of the kinase PHO80-PHO85 by the CDK inhibitor PHO81. Science (1994) 2.57

Biliary excretion in foreign compounds. Sulphonamide drugs in the rat. Biochem J (1967) 2.53

Biliary excretion in foreign compounds. Species difference in biliary excretion. Biochem J (1967) 2.52

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J (Clin Res Ed) (1982) 2.39

The metabolism of [14C]-debrisoquine in man. Br J Clin Pharmacol (1979) 2.29

Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology (1995) 2.26

Body malodour syndromes. Lancet (1995) 2.12

Nitrogen Fixation in Grasses Inoculated with Spirillum lipoferum. Science (1976) 2.09

Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica (1979) 2.07

Science, medicine, and the future: Pharmacogenetics. BMJ (2000) 2.06

Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos (2001) 1.96

Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun (1995) 1.95

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92

Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90

Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol (1999) 1.90

Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Anal Biochem (1979) 1.85

Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet (1997) 1.83

The metabolic fate of amphetamine in man and other species. Biochem J (1970) 1.80

A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis (1991) 1.78

The exogenous origin of trimethylamine in the mouse. Metabolism (1992) 1.78

The biliary excretion of tartrazine. Sex differences in the rat and species differences in the rat, guinea-pig and rabbit. J Pharm Pharmacol (1972) 1.77

Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Drug Metab Rev (1979) 1.71

D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol (1984) 1.69

Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69

Comparison of low- and high-passage bovine turbinate cells for assay of bovine viral diarrhea virus. Arch Gesamte Virusforsch (1974) 1.65

Use of molecular techniques to evaluate the survival of a microorganism injected into an aquifer. Appl Environ Microbiol (1994) 1.64

The fate of benzoic acid in various species. Biochem J (1970) 1.62

The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species. Br J Pharmacol Chemother (1965) 1.62

Short-term adaptation in single auditory nerve fibers: some poststimulatory effects. J Neurophysiol (1977) 1.59

Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care (1999) 1.58

Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochem J (1972) 1.57

The fish odour syndrome: biochemical, familial, and clinical aspects. BMJ (1993) 1.57

The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings]. Br J Clin Pharmacol (1977) 1.55

Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sci (1978) 1.55

Rapid and short-term adaptation in auditory nerve responses. Hear Res (1984) 1.52

The fate of amphetamine in man and other mammals. J Pharm Pharmacol (1966) 1.51

Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am (1999) 1.49

Inhibition of existing denitrification enzyme activity by chloramphenicol. Appl Environ Microbiol (1992) 1.47

Physician knowledge in the use of canister nebulizers. Chest (1983) 1.47

The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution. Br J Pharmacol Chemother (1965) 1.46

Alteration of the Fe protein of nitrogenase by oxygen in the cyanobacterium Anabaena sp. strain CA. J Bacteriol (1987) 1.44

The metabolism of 14C-labelled trimethylamine and its N-oxide in man. Xenobiotica (1987) 1.44

A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther (1987) 1.44

Prediction of glycosaminoglycan content in human cartilage by age, T1ρ and T2 MRI. Osteoarthritis Cartilage (2010) 1.43

Dynamic structure of membranes by deuterium NMR. Science (1984) 1.43

Prophylactic antibiotics in clean orthopaedic surgery. J Bone Joint Surg Am (1974) 1.43

Glucosaminidase, galactosaminidase, and glucuronidase in the growth plate. J Orthop Res (1990) 1.42

Embryotoxic activity of some pesticides and drugs related to phthalimide. Food Cosmet Toxicol (1965) 1.40

['Body-packer' syndrome: an important disease with forensic-medical aspects]. Ned Tijdschr Geneeskd (2003) 1.39

Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica (1976) 1.38

Adaptation, saturation, and physiological masking in single auditory-nerve fibers. J Acoust Soc Am (1979) 1.36

Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36

Bactericidal Activity of TiO2 Photocatalyst in Aqueous Media: Toward a Solar-Assisted Water Disinfection System. Environ Sci Technol (1994) 1.35

Encoding of amplitude modulation in the gerbil cochlear nucleus: I. A hierarchy of enhancement. Hear Res (1990) 1.35

Organization of the genes necessary for hydrogenase expression in Rhodobacter capsulatus. Sequence analysis and identification of two hyp regulatory mutants. Mol Microbiol (1993) 1.34

Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis (2000) 1.34

Stabilization and transport of severely ill infants. Pediatr Clin North Am (1973) 1.33

Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest (1988) 1.32

Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol (1984) 1.29

Isolation of Azospirullum from diverse geographic regions. Can J Microbiol (1979) 1.26

Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation. Clin Pharmacol Ther (1981) 1.26

Protecting poor metabolizers, a group at high risk of adverse drug reactions. Lancet (1983) 1.23

Cloning of the mgtE Mg2+ transporter from Providencia stuartii and the distribution of mgtE in gram-negative and gram-positive bacteria. J Bacteriol (1995) 1.22

The fibronectin adhesin of Candida albicans. Infect Immun (1994) 1.22

Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest (1992) 1.22

Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am (1995) 1.22

Short-term adaptation and incremental responses of single auditory-nerve fibers. Biol Cybern (1975) 1.21

Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia cell differentiation. J Biol Chem (1982) 1.20

Genetically determined oxidation capacity and the disposition of debrisoquine. Br J Clin Pharmacol (1983) 1.19

Ontogeny of cation-Cl- cotransporter expression in rat neocortex. Brain Res Dev Brain Res (1998) 1.18

Unplanned extubation. Chest (1995) 1.18

Restriction fragment length polymorphism evaluation of six peanut species within the Avachis section. Theor Appl Genet (1992) 1.18

Trimethylaminuria ('fish-odour syndrome'): a study of an affected family. Clin Sci (Lond) (1988) 1.18

The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc R Soc Lond B Biol Sci (1972) 1.17

The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein. J Biol Chem (1998) 1.17

The psychiatric training of medical students. Can J Psychiatry (1981) 1.17

Sex and species differences in the biliary excretion of tartrazine and lissamine fast yellow in the rat, guinea-pig and rabbit. The influence of sex hormones on tartrazine excretion in the rat. J Pharm Pharmacol (1972) 1.16

Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother (1991) 1.15

A validation of a scoring system to evaluate the condition of transported very-low-birthweight neonates. Am J Perinatol (1988) 1.15

Trimethylaminuria: the detection of carriers using a trimethylamine load test. J Inherit Metab Dis (1989) 1.15

Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice. J Reticuloendothel Soc (1974) 1.14

Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-α. Oncogene (2010) 1.13

Effect of an arginine-glycine-aspartic acid-containing peptide on hematogenous candidal infections in rabbits. Antimicrob Agents Chemother (1992) 1.13

Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures. J Clin Microbiol (1988) 1.12

Morphology and electrophysiology of guinea pig gastric mucosal repair in vitro. Am J Physiol (1983) 1.12

New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. J Med Chem (1991) 1.12

Pregnanes from defensive glands of a belostomatid bug. Experientia (1993) 1.12